Hunter C. Smith
Chief Financial Officer at Rhythm Pharmaceuticals. Based in Boston, Massachusetts.
- Rank
- 7113th of 14,644
- Companies held
- 1
- Largest holding
- RYTM, 100.0% of total
- Latest SEC filing
- Aug 31, 2026
What the $13.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals RYTM Common Stock | Directly | 114,024 | $116.47 | $13.3M | 100.0% | Form 4, Aug 31, 2026 |
Share counts are the amounts Hunter C. Smith reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Sold | RYTM | 11,514 | $105.37 | $1.2M | View |
| Aug 31, 2026 | Sold | RYTM | 23,072 | $104.59 | $2.4M | View |
| Aug 31, 2026 | Sold | RYTM | 28,188 | $106.20 | $3.0M | View |
| Feb 19, 2026 | Sold | RYTM | 1,308 | $100.27 | $131K | View |
| Feb 19, 2026 | Sold | RYTM | 1,692 | $100.92 | $171K | View |
| Feb 19, 2026 | Sold | RYTM | 800 | $102.10 | $82K | View |
| Feb 19, 2026 | Sold | RYTM | 585 | $103.28 | $60K | View |
| Feb 17, 2026 | Sold | RYTM | 200 | $100.52 | $20K | View |
| Feb 17, 2026 | Sold | RYTM | 900 | $101.70 | $92K | View |
| Feb 17, 2026 | Sold | RYTM | 1,069 | $103.00 | $110K | View |
| Feb 17, 2026 | Sold | RYTM | 1,200 | $99.42 | $119K | View |
| Feb 17, 2026 | Sold | RYTM | 200 | $103.84 | $21K | View |
| Feb 12, 2026 | Sold | RYTM | 100 | $100.10 | $10K | View |
| Feb 12, 2026 | Sold | RYTM | 800 | $98.99 | $79K | View |
| Feb 12, 2026 | Sold | RYTM | 400 | $97.67 | $39K | View |
| Feb 12, 2026 | Sold | RYTM | 292 | $96.26 | $28K | View |
| Feb 11, 2026 | Sold | RYTM | 2,266 | $98.37 | $223K | View |
| Feb 11, 2026 | Sold | RYTM | 100 | $100.85 | $10K | View |
| Feb 11, 2026 | Sold | RYTM | 400 | $99.44 | $40K | View |
| Feb 10, 2026 | Sold | RYTM | 700 | $103.68 | $73K | View |
| Feb 10, 2026 | Sold | RYTM | 100 | $104.76 | $10K | View |
| Feb 10, 2026 | Sold | RYTM | 1,913 | $102.66 | $196K | View |
| Feb 5, 2026 | Sold | RYTM | 3,381 | $106.06 | $359K | View |
| Feb 4, 2026 | Sold | RYTM | 1,500 | $104.74 | $157K | View |
| Feb 4, 2026 | Sold | RYTM | 747 | $107.67 | $80K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7110 | Melinda D. Whittington President & CEO, La-Z-Boy. Monroe, MI | $13.3M |
| 7111 | Philip L. Johnson EVP & Chief Financial Officer, Jazz Pharmaceuticals | $13.3M |
| 7112 | Michael Burkes Brophy CHIEF FINANCIAL OFFICER, Natera. Austin, TX | $13.3M |
| 7113 | Hunter C. Smith Chief Financial Officer, Rhythm Pharmaceuticals. Boston, MA | $13.3M |
| 7114 | Alexander Hardy Chief Executive Officer, BioMarin Pharmaceutical. San Rafael, CA | $13.3M |
| 7115 | Bernard Fried Director, Quanta Services. Houston, TX | $13.3M |
| 7116 | Steven W. Moster Chief Executive Officer, Pursuit Attractions and Hospitality. Phoenix, AZ | $13.3M |
Other Rhythm Pharmaceuticals insiders
All RYTM insiders- David P. Meeker$27.9MPresident and CEO. #3498 overall
- Yann Mazabraud$6.5MEVP, Head of International. #12074 overall
- Stuart A. Arbuckle$1.4MDirector. #3314 overall
- David W.J. McGirr$1.4MDirector. #6253 overall
- Camille L. Bedrosian$815KDirector. #9638 overall
Questions
How much stock does Hunter C. Smith own?
Hunter C. Smith holds $13,280,375 in listed stock based on SEC filings and current prices, mostly Rhythm Pharmaceuticals (RYTM). That ranks 7113th on the Stock Rich List.
Is this Hunter C. Smith's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Hunter C. Smith last buy or sell stock?
The most recent open-market trade on file is a sale of 11,514 RYTM shares on Aug 31, 2026 at $105.37.